TWO SIGMA INVESTMENTS, LP - ULTRAGENYX PHARMACEUTICAL IN ownership

ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 232 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q3 2022. The put-call ratio across all filers is 0.85 and the average weighting 0.1%.

Quarter-by-quarter ownership
TWO SIGMA INVESTMENTS, LP ownership history of ULTRAGENYX PHARMACEUTICAL IN
ValueSharesWeighting
Q3 2023$1,397,480
-92.5%
39,200
-90.3%
0.00%
-91.5%
Q2 2023$18,626,095
-4.9%
403,774
-17.3%
0.05%
-16.1%
Q1 2023$19,583,076
-4.4%
488,356
+10.5%
0.06%
-12.5%
Q4 2022$20,474,895
+93.6%
441,936
+73.0%
0.06%
+77.8%
Q3 2022$10,576,000
+213.7%
255,389
+352.0%
0.04%
+227.3%
Q2 2022$3,371,000
+19.3%
56,500
+45.2%
0.01%
+37.5%
Q1 2022$2,825,000
+20.9%
38,900
+50.2%
0.01%
+60.0%
Q3 2021$2,336,000
-91.6%
25,900
-91.1%
0.01%
-92.1%
Q2 2021$27,677,000
+68.4%
290,264
+101.1%
0.06%
+46.5%
Q1 2021$16,432,000
+96.8%
144,320
+139.3%
0.04%
+79.2%
Q4 2020$8,349,000
+1676.4%
60,312
+955.0%
0.02%
+1100.0%
Q3 2020$470,000
-84.8%
5,717
-85.5%
0.00%
-86.7%
Q2 2020$3,094,000
+831.9%
39,554
+409.8%
0.02%
+1400.0%
Q3 2019$332,000
+18.1%
7,759
+94.0%
0.00%0.0%
Q4 2016$281,000
-98.1%
4,000
-97.3%
0.00%
-98.6%
Q3 2015$14,457,000
-2.8%
150,113
+3.3%
0.07%
+7.2%
Q2 2015$14,881,000
+1769.5%
145,341
+1033.6%
0.07%
+1625.0%
Q1 2015$796,00012,8210.00%
Other shareholders
ULTRAGENYX PHARMACEUTICAL IN shareholders Q3 2022
NameSharesValueWeighting ↓
First Light Asset Management, LLC 213,887$29,608,0002.19%
Rock Springs Capital Management LP 566,500$78,421,0001.66%
FEDERATED HERMES, INC. 4,280,528$592,554,0001.21%
AtonRa Partners 17,646$2,443,0001.20%
EMERALD MUTUAL FUND ADVISERS TRUST 218,390$30,232,0001.05%
EMERALD ADVISERS, LLC 226,875$31,406,0001.04%
Atika Capital Management LLC 89,000$12,319,0000.96%
Capital Impact Advisors, LLC 25,582$3,541,0000.87%
JGP Global Gestao de Recursos Ltda. 1,586$220,0000.83%
CAPITAL INTERNATIONAL LTD /CA/ 79,742$11,039,0000.64%
View complete list of ULTRAGENYX PHARMACEUTICAL IN shareholders